Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen staff Lost Time Injury & Illness Rate (LTIR per 200,000 hours) (×)
Amgen Sustainability Reports
Latest, FY2025
0.07
Period ended Dec 31, 2025
Change on a year earlier
+40.0%
0.05 in FY2024
History
7 years
Since FY2019
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Staff Lost Time Injury & Illness Rate (LTIR per 200,000 hours) (×) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.07 | +40.0% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2024 | Dec 31, 2024 | 0.05 | -44.4% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2023 | Dec 31, 2023 | 0.09 | +80.0% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2022 | Dec 31, 2022 | 0.05 | -44.4% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2021 | Dec 31, 2021 | 0.09 | +12.5% | Amgen Sustainability Report (amgen-2025-sustainability-highlights-report.pdf) ↗ |
| FY2020 | Dec 31, 2020 | 0.08 | -33.3% | https://www.responsibilityreports.com/HostedData/ResponsibilityReportArchive/a/NASDAQ_AMGN_2023.pdf ↗ |
| FY2019 | Dec 31, 2019 | 0.12 | – | https://www.responsibilityreports.com/HostedData/ResponsibilityReportArchive/a/NASDAQ_AMGN_2023.pdf ↗ |
Cite this data
StockData. (2026). Amgen Staff Lost Time Injury & Illness Rate (LTIR per 200,000 hours) (×), annual FY2019–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/esg_ltir_staff
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.